Peanut oral immunotherapy (OIT) in clinical trials involving children was associated with substantially greater risk for anaphylaxis and other allergic reactions, compared to placebo or peanut avoidance, a systematic review found.
Source: Peanut OIT Anaphylaxis Risk Higher Than Placebo, Avoidance